glp-1 sleep apnea trial Zepbound: Weight Loss Drugs Can Help Reduce Symptoms Study: GLP-1 therapies reduce OSA

Sajad Zalzala, MD, SkinnyRx Medical Director The Future of Oral GLP-1s Oral GLP-1s are much newer, with Rybelsus only receiving FDA-approval in 2019

Heres what to know

People with obesity are more likely to be women and have lower incomes, and people with lower incomes are less likely to have good insurance coverage, said Edmond Wickham, a doctor who volunteers on the board of directors of the American Board of Obesity Medicine

$0 due todayonly charged if approved

A major advantage is that they can be given orally while a potential disadvantage is that other hormones could also be affected

And its going to determine who keeps the resultsand who ends up right back where they started